Target intelligence / Profile preview

Anaerobic Gram-negative oral bacteria

Molecular classification
Other
01

Overview

Anaerobic Gram-negative oral bacteria are a diverse group of microorganisms that inhabit the subgingival dental biofilm and are primarily responsible for the development of periodontal diseases. Key species, including Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola, utilize specialized virulence factors such as gingipains and lipopolysaccharides to degrade host tissues and modulate the immune response (Socransky et al., 1998, Journal of Clinical Periodontology; Hajishengallis, 2015, Nature Reviews Immunology). These bacteria are targeted in clinical practice through mechanical debridement and the use of systemic or local antimicrobial agents like metronidazole and chlorhexidine (Slots, 2017, Periodontology 2000). The persistence of these pathogens is linked not only to localized tissue destruction but also to systemic conditions, including cardiovascular disease and diabetes, due to the chronic inflammatory state they induce (Nunn, 2003, Dental Clinics of North America). Effective therapeutic strategies focus on reducing the load of these specific anaerobes while attempting to preserve the healthy commensal oral microbiota.

Other names
Periodontal pathogensSubgingival biofilm bacteriaRed complex bacteriaBlack-pigmented anaerobesOral anaerobic microbiota
02

Mechanism of action

Antimicrobial agents target these bacteria through several distinct pathways: nitroimidazoles like metronidazole undergo reductive activation to form reactive intermediates that cause DNA strand breakage; beta-lactams such as amoxicillin inhibit cell wall synthesis by targeting penicillin-binding proteins; tetracyclines like doxycycline and minocycline inhibit protein synthesis by binding to the 30S ribosomal subunit; and antiseptics like chlorhexidine cause non-specific disruption of the bacterial cytoplasmic membrane (StatPearls, 2023, Periodontitis; Slots, 2017, Periodontology 2000).

03

Biological functions

Biofilm formationAnaerobic metabolismProteolysisHost immune evasionInterspecies signaling
04

Disease associations

PeriodontitisGingivitisEndodontic infectionPeri-implantitisSystemic inflammation
05

Safety considerations

Development of antimicrobial resistanceDisruption of the commensal oral microbiomeGastrointestinal side effectsHypersensitivity reactionsTooth staining (associated with chlorhexidine)
06

Interacting drugs

Metronidazole

5 more in the full profile.

07

Biomarkers

Probing pocket depth (PPD)Bleeding on probing (BOP)Clinical attachment loss (CAL)Porphyromonas gingivalis DNA levelsGingival crevicular fluid (GCF) cytokine levels

Beyond the preview

Go deeper on Anaerobic Gram-negative oral bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaerobic Gram-negative oral bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call